Academic Health Center
Stay Connected
research-and-clinical-trials

U of M, Harvard partner in search for answers to diabetic kidney disease

Last October, Health Talk told you about a new University of Minnesota and Harvard University partnership involving a clinical trial called Preventing Early Renal Loss in Diabetes (PERL) that will help researchers gain a better understanding around improving the health of people with diabetes and kidney complications.

As part of National Kidney Month, which wraps up at the end of March, Health Talk wanted to revisit the PERL study in an effort to raise awareness on the prevalence and public health concerns that kidney disease in type 1 diabetes causes on the American public and its health system.

Read more
research-and-clinical-trials

Are you at risk for type 2 diabetes? Take the test and find out

Today is American Diabetes Association Alert Day, a one-day “wake-up call” asking Americans to take the Diabetes Risk Test to find out if they are at risk for developing type 2 diabetes.

According to the ADA, 79 million Americans, or one in three adults, have prediabetes, putting adults at an increased risk for developing type 2 diabetes. Oftentimes a diabetes diagnosis comes up to 7-10 years after disease onset causing major medical complications and even death. That’s why early diagnosis is vital to successfully treat and possibly delay or prevent type 2 diabetes complications including heart disease, blindness, kidney disease, stroke and death.

The Diabetes Risk Test is simple and you only have to answer questions like weight, age, family history and other potential risk factors for prediabetes and type 2 diabetes.

Read more
in-the-news

In the News: U of M offers new cancer treatment for neuroblastoma

Neuroblastoma, a type of childhood cancer, is difficult to treat. And according to the American Cancer Institute, about 700 people in the United States are diagnosed with this form of cancer each year.

Raymond Yeager has dealt with the neuroblastoma since he was 14 years old. Now 20, he’s undergone many treatments including chemotherapy, radiation therapy, surgery, a stem cell transplant and immunotherapy. Unfortunately, nothing has helped…

Read more
expert-perspectives

Make the most out of Daylight Saving Time

This weekend, we spring ahead and lose an hour of sleep as part of Daylight Saving Time. For many people, this may create some problems only because they forgot to set their clock ahead before going to bed.

For those who tend to be night owls, shift workers, or who have sleep disorders, it can be more problematic. The additional loss of precious sleep can be a more substantial problem. When we are sleepy, we often don’t perform as well at work and are more likely to make mistakes and have car accidents.

Read more
in-the-news

In the News: U of M doctor offers expertise on rare condition

Teenagers Jonathon and Christopher Naquin of Humble, Texas have never been able to pinpoint the cause of their mysterious symptoms.

Since childhood, Jonathon, 18, and Christopher, 16, experienced significant levels of protein and blood in their urine and even suffered hearing loss while in elementary school.

But now, after years of tests and baffling doctors, the two boys and their family finally received the answer they were looking for: Alport Syndrome. Never heard of it? You’re not alone…

Read more
patient-care

What is an ACL injury and how is it treated?

Read more